Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 37 studies | 34% ± 17% | |
endothelial cell of lymphatic vessel | 17 studies | 35% ± 14% | |
capillary endothelial cell | 14 studies | 34% ± 16% | |
vein endothelial cell | 8 studies | 27% ± 11% | |
endothelial cell of artery | 6 studies | 43% ± 18% | |
Mueller cell | 6 studies | 52% ± 13% | |
endothelial cell of vascular tree | 6 studies | 31% ± 15% | |
glomerular endothelial cell | 4 studies | 68% ± 10% | |
mesothelial cell | 4 studies | 23% ± 1% | |
club cell | 3 studies | 26% ± 10% | |
endothelial cell of sinusoid | 3 studies | 51% ± 33% |
Insufficient scRNA-seq data for expression of KDR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 7733.09 | 459 / 459 | 97% | 24.98 | 1083 / 1118 |
thymus | 100% | 10976.08 | 653 / 653 | 92% | 47.98 | 559 / 605 |
adrenal gland | 99% | 3190.33 | 255 / 258 | 89% | 28.90 | 205 / 230 |
lung | 100% | 7043.97 | 577 / 578 | 88% | 23.88 | 1015 / 1155 |
prostate | 98% | 3671.00 | 240 / 245 | 87% | 14.84 | 438 / 502 |
stomach | 93% | 1882.72 | 334 / 359 | 85% | 13.36 | 243 / 286 |
kidney | 100% | 3809.36 | 89 / 89 | 76% | 91.45 | 683 / 901 |
bladder | 95% | 2481.62 | 20 / 21 | 72% | 9.64 | 362 / 504 |
esophagus | 84% | 2365.30 | 1212 / 1445 | 79% | 12.56 | 145 / 183 |
intestine | 85% | 1718.34 | 824 / 966 | 76% | 10.20 | 399 / 527 |
uterus | 100% | 10754.09 | 170 / 170 | 54% | 6.52 | 250 / 459 |
pancreas | 60% | 767.77 | 197 / 328 | 87% | 15.22 | 154 / 178 |
skin | 63% | 1237.70 | 1143 / 1809 | 81% | 14.79 | 384 / 472 |
brain | 32% | 413.82 | 852 / 2642 | 89% | 13.47 | 630 / 705 |
liver | 46% | 872.51 | 104 / 226 | 74% | 11.36 | 300 / 406 |
ovary | 68% | 1330.49 | 123 / 180 | 51% | 4.83 | 218 / 430 |
adipose | 100% | 9147.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.42 | 1 / 1 |
heart | 97% | 2849.28 | 838 / 861 | 0% | 0 | 0 / 0 |
spleen | 81% | 1192.35 | 196 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 81% | 2057.83 | 1080 / 1335 | 0% | 0 | 0 / 0 |
muscle | 66% | 889.24 | 527 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 53% | 7.88 | 24 / 45 |
lymph node | 0% | 0 | 0 / 0 | 41% | 3.84 | 12 / 29 |
eye | 0% | 0 | 0 / 0 | 38% | 4.85 | 30 / 80 |
peripheral blood | 0% | 1.48 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901532 | Biological process | regulation of hematopoietic progenitor cell differentiation |
GO_0001541 | Biological process | ovarian follicle development |
GO_0007275 | Biological process | multicellular organism development |
GO_0003157 | Biological process | endocardium development |
GO_0038084 | Biological process | vascular endothelial growth factor signaling pathway |
GO_0002053 | Biological process | positive regulation of mesenchymal cell proliferation |
GO_0043129 | Biological process | surfactant homeostasis |
GO_0030513 | Biological process | positive regulation of BMP signaling pathway |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_1903010 | Biological process | regulation of bone development |
GO_0060837 | Biological process | blood vessel endothelial cell differentiation |
GO_0050927 | Biological process | positive regulation of positive chemotaxis |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0035924 | Biological process | cellular response to vascular endothelial growth factor stimulus |
GO_0072089 | Biological process | stem cell proliferation |
GO_0050673 | Biological process | epithelial cell proliferation |
GO_0001525 | Biological process | angiogenesis |
GO_2000352 | Biological process | negative regulation of endothelial cell apoptotic process |
GO_0051901 | Biological process | positive regulation of mitochondrial depolarization |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0090050 | Biological process | positive regulation of cell migration involved in sprouting angiogenesis |
GO_0045165 | Biological process | cell fate commitment |
GO_0016239 | Biological process | positive regulation of macroautophagy |
GO_0010463 | Biological process | mesenchymal cell proliferation |
GO_2001214 | Biological process | positive regulation of vasculogenesis |
GO_1904881 | Biological process | cellular response to hydrogen sulfide |
GO_0001945 | Biological process | lymph vessel development |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0035162 | Biological process | embryonic hemopoiesis |
GO_0051770 | Biological process | positive regulation of nitric-oxide synthase biosynthetic process |
GO_0045446 | Biological process | endothelial cell differentiation |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0048597 | Biological process | post-embryonic camera-type eye morphogenesis |
GO_0001570 | Biological process | vasculogenesis |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0038083 | Biological process | peptidyl-tyrosine autophosphorylation |
GO_0002070 | Biological process | epithelial cell maturation |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0001569 | Biological process | branching involved in blood vessel morphogenesis |
GO_2001028 | Biological process | positive regulation of endothelial cell chemotaxis |
GO_0003158 | Biological process | endothelium development |
GO_0051894 | Biological process | positive regulation of focal adhesion assembly |
GO_0048010 | Biological process | vascular endothelial growth factor receptor signaling pathway |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0016477 | Biological process | cell migration |
GO_0048286 | Biological process | lung alveolus development |
GO_0055074 | Biological process | calcium ion homeostasis |
GO_0090141 | Biological process | positive regulation of mitochondrial fission |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0002042 | Biological process | cell migration involved in sprouting angiogenesis |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_2000648 | Biological process | positive regulation of stem cell proliferation |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0036324 | Biological process | vascular endothelial growth factor receptor-2 signaling pathway |
GO_0008360 | Biological process | regulation of cell shape |
GO_0061042 | Biological process | vascular wound healing |
GO_0071526 | Biological process | semaphorin-plexin signaling pathway |
GO_0043408 | Biological process | regulation of MAPK cascade |
GO_0045121 | Cellular component | membrane raft |
GO_0005768 | Cellular component | endosome |
GO_0005634 | Cellular component | nucleus |
GO_0005576 | Cellular component | extracellular region |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005769 | Cellular component | early endosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0097443 | Cellular component | sorting endosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0070161 | Cellular component | anchoring junction |
GO_0030054 | Cellular component | cell junction |
GO_0005021 | Molecular function | vascular endothelial growth factor receptor activity |
GO_0051879 | Molecular function | Hsp90 protein binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0015026 | Molecular function | coreceptor activity |
GO_0038085 | Molecular function | vascular endothelial growth factor binding |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
GO_0005178 | Molecular function | integrin binding |
GO_0019838 | Molecular function | growth factor binding |
Gene name | KDR |
Protein name | Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309) Kinase insert domain receptor (EC 2.7.10.1) Vascular endothelial growth factor receptor 2 (EC 2.7.10.1) Vascular endothelial growth factor receptor 2 variant (EC 2.7.10.1) |
Synonyms | FLK1 VEGFR2 |
Description | FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis. Promotes proliferation, survival, migration and differentiation of endothelial cells. Promotes reorganization of the actin cytoskeleton. Isoforms lacking a transmembrane domain, such as isoform 2 and isoform 3, may function as decoy receptors for VEGFA, VEGFC and/or VEGFD. Isoform 2 plays an important role as negative regulator of VEGFA- and VEGFC-mediated lymphangiogenesis by limiting the amount of free VEGFA and/or VEGFC and preventing their binding to FLT4. Modulates FLT1 and FLT4 signaling by forming heterodimers. Binding of vascular growth factors to isoform 1 leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate and the activation of protein kinase C. Mediates activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, reorganization of the actin cytoskeleton and activation of PTK2/FAK1. Required for VEGFA-mediated induction of NOS2 and NOS3, leading to the production of the signaling molecule nitric oxide (NO) by endothelial cells. Phosphorylates PLCG1. Promotes phosphorylation of FYN, NCK1, NOS3, PIK3R1, PTK2/FAK1 and SRC. . |
Accessions | A0A0U2X4C8 A0A0H4AF76 ENST00000263923.5 [P35968-1] A0A0H4A777 A0A0H4A7S0 A0A0U2WZU8 A0A0H4ADZ1 A0A0H4A7S4 P35968 A0A0U2VU55 A0A0H4AF85 |